PDF(Sci-hub)
Abstract：
With the development of increasingly effective antiemetic regimens, guideline adherence can prevent 70%-80% of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.
This quality improvement project aims to increase rates of adherence to national guidelines and, ultimately, decrease rates of CINV experienced by patients receiving highly emetogenic chemotherapy.
A retrospective chart analysis was performed. In-person education was provided to staff nurses and advanced practice providers on guidelines, followed by a survey immediately postintervention and again at three months.
Prior to the intervention, 49% of patients were found to experience CINV, with only 7% receiving guideline-appropriate prophylaxis. At three months, 37% of patients experienced CINV, with 22% receiving appropriate prophylaxis.
This quality improvement project aims to increase rates of adherence to national guidelines and, ultimately, decrease rates of CINV experienced by patients receiving highly emetogenic chemotherapy.
A retrospective chart analysis was performed. In-person education was provided to staff nurses and advanced practice providers on guidelines, followed by a survey immediately postintervention and again at three months.
Prior to the intervention, 49% of patients were found to experience CINV, with only 7% receiving guideline-appropriate prophylaxis. At three months, 37% of patients experienced CINV, with 22% receiving appropriate prophylaxis.
摘要：
随着越来越有效的止吐方案的发展，指南依从性可以预防70%-80%的癌症患者化疗引起的恶心和呕吐（CINV）。
这个质量改进项目旨在提高对国家指导方针的遵守率，最终,接受高度致吐化疗的患者经历的CINV下降率。
进行回顾性图表分析。向工作人员护士和高级实践提供者提供了有关指南的当面教育，随后在干预后立即进行调查，并在三个月后再次进行调查。
在干预之前，49%的患者被发现经历CINV，只有7%接受指南适当的预防。三个月后,37%的患者经历了CINV，22%接受适当的预防。
这个质量改进项目旨在提高对国家指导方针的遵守率，最终,接受高度致吐化疗的患者经历的CINV下降率。
进行回顾性图表分析。向工作人员护士和高级实践提供者提供了有关指南的当面教育，随后在干预后立即进行调查，并在三个月后再次进行调查。
在干预之前，49%的患者被发现经历CINV，只有7%接受指南适当的预防。三个月后,37%的患者经历了CINV，22%接受适当的预防。
